Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
U4 spliceosomal RNA (U4 snRNA) is a non-coding RNA component of the major spliceosome, a large ribonucleoprotein complex responsible for removing introns from pre-messenger RNA (pre-mRNA) in eukaryotes[1][3]. U4 snRNA forms a duplex with U6 snRNA, regulating the catalytic activity of the spliceosome by preventing U6 from adopting its active conformation before the proper stage of splicing[1][2][7]. The dissociation of U4 from U6, mediated by protein Brr2, is essential for activating the spliceosome's catalytic core. U4 is also central to assembling the U4/U6.U5 tri-snRNP, with its structure stabilized by a ring of Sm proteins—a unique feature of spliceosomal snRNAs[3]. While not directly catalyzing splicing, U4 snRNA serves as an RNA chaperone and structural organizer, ensuring correct spliceosome assembly and function. Genetic variants in U4 (e.g., RNU4-2) can disrupt spliceosomal activity and are implicated in rare inherited diseases, although U4 is not a current drug target[9].
Not applicable. No drugs target this RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U4 spliceosomal RNA (U4 snRNA).